Free Trial

LifeMD (LFMD) Competitors

LifeMD logo
$6.64 +0.01 (+0.15%)
Closing price 10/8/2025 04:00 PM Eastern
Extended Trading
$6.74 +0.10 (+1.51%)
As of 08:23 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LFMD vs. AHCO, PNTG, CDNA, FTRE, FLGT, CSTL, INNV, PSNL, AUNA, and TALK

Should you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include AdaptHealth (AHCO), The Pennant Group (PNTG), CareDx (CDNA), Fortrea (FTRE), Fulgent Genetics (FLGT), Castle Biosciences (CSTL), InnovAge (INNV), Personalis (PSNL), Auna (AUNA), and Talkspace (TALK). These companies are all part of the "healthcare" industry.

LifeMD vs. Its Competitors

LifeMD (NASDAQ:LFMD) and AdaptHealth (NASDAQ:AHCO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

In the previous week, LifeMD had 20 more articles in the media than AdaptHealth. MarketBeat recorded 25 mentions for LifeMD and 5 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 0.24 beat LifeMD's score of 0.11 indicating that AdaptHealth is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeMD
1 Very Positive mention(s)
2 Positive mention(s)
21 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
AdaptHealth
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

AdaptHealth has a net margin of 2.49% compared to LifeMD's net margin of -2.41%. AdaptHealth's return on equity of 5.01% beat LifeMD's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeMD-2.41% N/A -8.11%
AdaptHealth 2.49%5.01%1.77%

LifeMD presently has a consensus target price of $13.17, suggesting a potential upside of 98.29%. AdaptHealth has a consensus target price of $13.40, suggesting a potential upside of 49.55%. Given LifeMD's stronger consensus rating and higher possible upside, equities research analysts plainly believe LifeMD is more favorable than AdaptHealth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeMD
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.67
AdaptHealth
2 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.43

AdaptHealth has higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$212.45M1.48-$18.88M-$0.21-31.62
AdaptHealth$3.26B0.37$90.42M$0.5416.59

35.5% of LifeMD shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 18.4% of LifeMD shares are owned by insiders. Comparatively, 1.6% of AdaptHealth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

LifeMD has a beta of 1.67, indicating that its stock price is 67% more volatile than the S&P 500. Comparatively, AdaptHealth has a beta of 1.61, indicating that its stock price is 61% more volatile than the S&P 500.

Summary

AdaptHealth beats LifeMD on 9 of the 16 factors compared between the two stocks.

Get LifeMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFMD vs. The Competition

MetricLifeMDMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$314.38M$8.17B$6.09B$10.54B
Dividend YieldN/A2.83%5.69%4.71%
P/E Ratio-31.6274.0085.4827.61
Price / Sales1.4832.99535.60201.12
Price / CashN/A22.8037.9261.55
Price / Book-73.786.9712.976.76
Net Income-$18.88M$247.60M$3.30B$275.88M
7 Day Performance-4.05%1.11%4.35%2.81%
1 Month Performance9.21%0.75%9.50%9.24%
1 Year Performance49.21%13.32%84.38%35.42%

LifeMD Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFMD
LifeMD
3.5155 of 5 stars
$6.64
+0.2%
$13.17
+98.3%
+42.2%$314.38M$212.45M-31.62230Analyst Forecast
AHCO
AdaptHealth
3.6321 of 5 stars
$8.68
-2.4%
$13.40
+54.4%
-12.7%$1.20B$3.26B16.0710,500Analyst Forecast
PNTG
The Pennant Group
4.0529 of 5 stars
$25.18
-0.9%
$34.40
+36.6%
-24.3%$877.88M$695.24M32.287,000
CDNA
CareDx
4.6298 of 5 stars
$14.86
-0.5%
$25.50
+71.6%
-54.0%$794.68M$333.79M14.57740News Coverage
Analyst Forecast
FTRE
Fortrea
3.0531 of 5 stars
$8.40
-3.2%
$11.50
+36.9%
-45.7%$788.14M$2.70B-0.7415,500News Coverage
Analyst Upgrade
Gap Up
FLGT
Fulgent Genetics
3.1274 of 5 stars
$22.30
-1.3%
$25.33
+13.6%
+11.2%$691.46M$283.47M-13.431,313Analyst Forecast
CSTL
Castle Biosciences
2.5969 of 5 stars
$22.36
-1.5%
$37.00
+65.5%
-21.4%$658.78M$332.07M-63.88540Analyst Forecast
INNV
InnovAge
0.5392 of 5 stars
$4.90
+2.1%
$5.00
+2.0%
+7.4%$651.06M$853.70M-21.302,440Analyst Forecast
PSNL
Personalis
3.0922 of 5 stars
$6.35
+5.1%
$7.42
+16.8%
+66.6%$535.61M$84.61M-4.96400Analyst Forecast
AUNA
Auna
4.0874 of 5 stars
$6.66
flat
$10.70
+60.7%
-2.7%$492.93M$1.17B7.5714,842Positive News
TALK
Talkspace
3.8428 of 5 stars
$2.76
-0.7%
$4.50
+63.0%
+25.3%$465.56M$187.59M138.07500News Coverage
Analyst Downgrade

Related Companies and Tools


This page (NASDAQ:LFMD) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners